Hangzhou Diagens Biotechnology Co., Ltd.

HK$99.85As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2526Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Medical Devices
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$8.875B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$118
18.61%
(12.72%)
Hold 10|4|7|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.59
1.71
1.63
1.72
12.47%
18.38%
5.43%
6.34%
Revenue¥M
688.8
696.0
721.3
737.2
6.79%
11.19%
13.17%
9.27%
Peers (US$1.132B)
Cap (US$)
PE
1.108B
—
1.106B
412.0x
Capital
TTM
5Y
10Y
Leveragex
1.355
0.525
0.450
EBIT/Intx
0.433
0.268
0.272
Own earn%
(12.36)
71.18
65.84
Sh yield%
25.50
29.35
30.41
Owners
Insiders/Inst%
9.13
54.11
Short interest%
5.99
SBC / revenue%
3.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–19
$1 testx
—
Incr. ROIC%
7